TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab
- Status
- COMPLETED
- Phase
- PHASE2
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Adjuvant Therapy With Anlotinib for HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Deep Liver Phenotyping and Immunology Study
- Status
- RECRUITING
- Phase
- N/A
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC
- Status
- UNKNOWN
- Phase
- N/A
Low Dose ICG for Biliary Tract and Tumor Imaging
- Status
- COMPLETED
- Phase
- PHASE2
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC
- Status
- UNKNOWN
- Phase
- N/A
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Status
- RECRUITING
- Phase
- PHASE2
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres
- Status
- COMPLETED
- Phase
- N/A
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI
- Status
- COMPLETED
- Phase
- NA
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
SBRT + Atezolizumab + Bevacizumab in Resectable HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1